Online event
Link visible for attendees
Sponsors
Details
Dr. Connor W. Coley, Assistant Professor at MIT in the Dept. of Chemical Engineering, will present: "Data-driven chemistry, small molecule synthesis, and design."
We will hold the event online, starting at 6pm with Connor's presentation and Q&A;, followed by some time for networking in Zoom breakout rooms for those who can stay and who would like to catch up with the community.
ABSTRACT
The typical molecular discovery paradigm is an iterative process of designing candidate compounds, synthesizing those compounds, and testing their performance, where each repeat of this cycle can require weeks or months, requires extensive manual effort, and relies on expert intuition. This talk will describe our efforts to accelerate the process of molecular discovery from two interrelated angles. The first involves facilitating the chemical synthesis of new structures through data-driven computer-aided synthesis planning, where we can learn patterns of chemical reactivity directly from tabulated organic reaction data. The second involves prioritizing candidate molecules to test using machine learning models for molecular property prediction. Together, these studies illustrate how data science and statistical learning offer unprecedented opportunities to systematize and streamline the process by which new functional small molecules are designed and synthesized.
BIO
Connor W. Coley is an Assistant Professor at MIT in the Department of Chemical Engineering with a shared appointment in the Department of Electrical Engineering and Computer Science. His work in computer assistance and automation for organic synthesis has included the development of a data-driven synthesis planning program and in silico strategies for predicting the outcomes of organic reactions. His continuing research interests are in how data science, statistical learning, and laboratory automation can be used to streamline discovery in the chemical sciences. Connor has been named one of C&EN;’s “Talented Twelve” and one of Forbes Magazine’s “30 Under 30” for Healthcare. He received his B.S. and Ph.D. in Chemical Engineering from Caltech and MIT, respectively, and did his postdoctoral training at the Broad Institute.
